EFFECTOR THERAPEUTICS, INC. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2016-02-22. The offering totals $56.0M, of which $56.0M was reported sold. Industry: Biotechnology.
Showing 25 of 37 people.
| Name | Role | Location |
|---|---|---|
| Simeon T George | Director | San Diego, CA |
| Markus T Goebel | Director | San Diego, CA |
| Ken T Haas | Director | San Diego, CA |
| Maha T Katabi | Director | Boston, MA |
| Laurence T Lasky | Director | San Diego, CA |
| David T Maki | Director | Lexington, MA |
| Jonathan T Root | Director | San Diego, CA |
| Alana T McNulty | Executive Officer | San Diego, CA |
| Denis W Patrick, Ph.D. | Director | San Diego, CA |
| Stephen T Worland, Ph.D. | Director | San Diego, CA |
| Stephen T Worland, Ph.D. | Executive Officer | San Diego, CA |
| John W Smither | Director | San Diego, CA |
| Stefan D Larson, Ph.D. | Director | San Diego, CA |
| Alana D McNulty | Executive Officer | San Diego, CA |
| David D Maki, J.D. | Director | San Diego, CA |
| Jonathan D Root, M.D. | Director | San Diego, CA |
| Kenneth J Haas, J.D. | Director | San Diego, CA |
| Simeon J George, M.D. | Director | San Diego, CA |
| Laurence T Lasky, Ph.D. | Director | San Diego, CA |
| Jeremy D Barton, M.D. | Executive Officer | San Diego, CA |
| Maha D Katabi, Ph.D. | Director | San Diego, CA |
| Markus J Goebel, M.D., Ph.D. | Director | San Diego, CA |
| Elaine D Jones, Ph.D. | Director | San Diego, CA |
| Stephen F Worland, Ph.D. | Director | San Diego, CA |
| Stephen F Worland, Ph.D. | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-05-14 | D | $21.8M | $20.4M |
| 2017-07-27 | D | $38.6M | $16.8M |
| 2015-12-23 | D | $45.0M | $40.0M |
| 2015-07-24 | D/A | $57.0M | $36.2M |
| 2014-08-14 | D/A | $57.0M | $21.5M |
| 2013-05-28 | D | $46.4M | $17.4M |